Teleflex (NYSE:TFX) Upgraded to Neutral at Bank of America

Teleflex (NYSE:TFX) was upgraded by investment analysts at Bank of America from an “underperform” rating to a “neutral” rating in a research report issued on Monday, Marketbeat.com reports. The brokerage currently has a $135.00 target price on the medical technology company’s stock. Bank of America‘s price target indicates a potential upside of 12.04% from the stock’s previous close.

Other research analysts also recently issued reports about the stock. Raymond James Financial raised shares of Teleflex from a “market perform” rating to an “outperform” rating and set a $128.00 price objective on the stock in a research report on Friday, March 27th. Wells Fargo & Company boosted their price objective on shares of Teleflex from $116.00 to $130.00 and gave the company an “equal weight” rating in a research report on Friday, February 27th. Truist Financial boosted their price objective on shares of Teleflex from $120.00 to $135.00 and gave the company a “hold” rating in a research report on Thursday, December 18th. Zacks Research downgraded shares of Teleflex from a “hold” rating to a “strong sell” rating in a research report on Monday, March 2nd. Finally, Royal Bank Of Canada increased their price objective on Teleflex from $115.00 to $125.00 and gave the stock a “sector perform” rating in a report on Friday, February 27th. Three equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Teleflex presently has an average rating of “Hold” and an average price target of $138.50.

Teleflex Trading Up 1.8%

Shares of Teleflex stock traded up $2.10 during trading on Monday, hitting $120.49. The stock had a trading volume of 17,223 shares, compared to its average volume of 932,592. The stock has a 50 day simple moving average of $111.84 and a 200 day simple moving average of $116.00. The company has a market capitalization of $5.33 billion, a PE ratio of -5.85, a P/E/G ratio of 0.74 and a beta of 0.84. The company has a quick ratio of 2.01, a current ratio of 2.54 and a debt-to-equity ratio of 0.81. Teleflex has a 1 year low of $100.18 and a 1 year high of $138.93.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, February 26th. The medical technology company reported $1.93 earnings per share for the quarter, missing analysts’ consensus estimates of $3.73 by ($1.80). The business had revenue of $569.00 million during the quarter, compared to analyst estimates of $912.57 million. Teleflex had a negative net margin of 30.56% and a positive return on equity of 14.30%. Teleflex’s revenue for the quarter was down 28.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $3.89 EPS. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. On average, research analysts expect that Teleflex will post 13.98 EPS for the current fiscal year.

Hedge Funds Weigh In On Teleflex

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. MassMutual Private Wealth & Trust FSB grew its holdings in Teleflex by 57.9% during the third quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company’s stock valued at $26,000 after purchasing an additional 77 shares during the last quarter. Banque Cantonale Vaudoise grew its holdings in Teleflex by 82.5% during the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock valued at $31,000 after purchasing an additional 113 shares during the last quarter. Hantz Financial Services Inc. grew its holdings in Teleflex by 248.8% during the third quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock valued at $34,000 after purchasing an additional 199 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. acquired a new position in Teleflex during the third quarter valued at approximately $35,000. Finally, V Square Quantitative Management LLC acquired a new position in Teleflex during the fourth quarter valued at approximately $37,000. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.